JECHO Biopharmaceuticals Co., Ltd, located in Sino-Singapore Tianjin Eco-city, is a Sino-foreign high-tech joint venture focusing on R&D, production and sales of biopharmaceuticals.

As a key investment project in Binhai New Area as well as the company focusing on biopharmaceuticals innovation locating in Sino-Singapore Tianjin Eco-city, we fully meet international and domestic biopharmaceutical industry standards such as FDA, EMA and GMP from construction to operation and management, and comply with its relevant regulations. Our company has established the Academic & Expert Station, Post-Doctoral Research Station, which provides strong and sustainable support for promoting the industrialization of scientific and technological achievements, innovative talent training, and enhancing the capacity for independent innovation.

Our products cover the frontier of biopharmaceuticals.

Our products cover monoclonal antibodies, recombinant proteins, oncolytic viruses, immunotoxins and vaccines. We provide global customers with competitive products and value-added services. Relying on independent intellectual property rights, strong innovation and projects with competitive prospects, JECHO will become a base integrating R&D, production and sales of high-end biopharmaceutical.

JECHO has taken the road of independent innovation. While developing ourselves with talented staff, industry standard hardware and software systems, facilities and management systems, we also provide global customers with a series of services such as cooperative biopharmaceutical R&D and commissioned production, as well as complete solutions through cell line screening, mass production of finished products and launch.

JECHO’s overall operation meets the biopharmaceutical standards of R&D and production, facility design and construction in Europe and America, and a complete biopharmaceutical industry chain has been built through research and development and mass production.